Ingevity Corporation
NGVT
$71.98
$1.061.50%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 258.00M | 255.10M | 333.10M | 331.50M | 247.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 258.00M | 255.10M | 333.10M | 331.50M | 247.90M |
| Cost of Revenue | 141.60M | 167.30M | 199.20M | 203.60M | 136.00M |
| Gross Profit | 116.40M | 87.80M | 133.90M | 127.90M | 111.90M |
| SG&A Expenses | 40.70M | 41.60M | 44.10M | 43.60M | 41.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 189.00M | 216.30M | 250.30M | 254.20M | 184.90M |
| Operating Income | 69.00M | 38.80M | 82.80M | 77.30M | 63.00M |
| Income Before Tax | 30.20M | -105.30M | 62.20M | -136.50M | 37.60M |
| Income Tax Expenses | 6.80M | -26.50M | 21.40M | 4.90M | 8.50M |
| Earnings from Continuing Operations | 23.40M | -78.80M | 40.80M | -141.40M | 29.10M |
| Earnings from Discontinued Operations | 36.40M | -5.80M | 2.70M | -5.10M | -8.60M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.80M | -84.60M | 43.50M | -146.50M | 20.50M |
| EBIT | 69.00M | 38.80M | 82.80M | 77.30M | 63.00M |
| EBITDA | 90.40M | 66.60M | 108.40M | 98.10M | 87.90M |
| EPS Basic | 1.70 | -2.37 | 1.20 | -4.02 | 0.56 |
| Normalized Basic EPS | 0.91 | 0.12 | 1.11 | 1.00 | 0.70 |
| EPS Diluted | 1.66 | -2.37 | 1.17 | -4.02 | 0.56 |
| Normalized Diluted EPS | 0.90 | 0.12 | 1.09 | 1.00 | 0.70 |
| Average Basic Shares Outstanding | 35.26M | 35.70M | 36.31M | 36.42M | 36.38M |
| Average Diluted Shares Outstanding | 36.02M | 35.70M | 36.96M | 36.42M | 36.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |